Live intraday price
Compare with our price levels
Close 2026-09-30: $72.30 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)
Not in the buy zone yet — needs to drop 5.2% · 1 whale recently bought
🎯 Trade plan by price level
Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks
Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated
Risk : reward 1 : 1.5Moves ~$7.15 a day
⚖️ Positives and risks
- ●1 whale bought or added last quarter
- ●Fresh Golden Cross (MA50 crossed above MA200)
- ●Average analyst price target 90.44 (upside +25%, 9 analysts)
- ●Most analysts rate it Strong Buy
- ●Long-term downtrend (below a falling MA200)
- ●Company is still losing money (negative net margin)
- ●High forward P/E of 76x (lots of growth already priced in)
🕯️ Price chart
Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold
🐋 Whales holding this stock
From each whale's latest quarterly filing
👔 Insider buying & selling
Latest trades from SEC Form 4 filings
Stueland Katherine · CEO · Director
2026-09-16 · 4,141 shares @ $98.27
Stueland Katherine · CEO · Director
2026-09-16 · 3,039 shares @ $99.00
Stueland Katherine · CEO · Director
2026-09-16 · 1,648 shares @ $94.26
Stueland Katherine · CEO · Director
2026-09-16 · 1,525 shares @ $96.90
Feeley Kevin · CFO
2026-09-16 · 1,470 shares @ $98.27
Feeley Kevin · CFO
2026-09-16 · 1,079 shares @ $99.00
Feeley Kevin · CFO
2026-09-16 · 586 shares @ $94.26
Feeley Kevin · CFO
2026-09-16 · 541 shares @ $96.90
Stueland Katherine · CEO · Director
2026-09-16 · 148 shares @ $95.41
Feeley Kevin · CFO
2026-09-16 · 52 shares @ $95.41
Stueland Katherine · CEO · Director
2026-09-09 · 3,692 shares @ $84.22
Feeley Kevin · CFO
2026-09-09 · 1,285 shares @ $84.22
Feeley Kevin · CFO
2026-09-01 · 372 shares @ $83.84
Stueland Katherine · CEO · Director
2026-06-16 · 5,932 shares @ $60.83
Stueland Katherine · CEO · Director
2026-06-16 · 2,429 shares @ $61.50
💬 User reviews
Rate and review this stock (sign-in required) — reviews don't affect the system's scores
Loading…
Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person
📰 Latest news
GeneDx Stock Is Down 30% In Last 1 Year, Can It Climb Again in 2027?
TIKR · 2026-09-24
3 Promising Genomics Stocks in the Spotlight in 2026
Zacks · 2026-09-08
Top Stock Picks for Week of August 24, 2026
Zacks · 2026-08-24
Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?
Zacks · 2026-08-19
GeneDx (WGS) Q2 2026 Earnings Call Transcript
Motley Fool · 2026-08-11
🔬 Deep dive
For those who want the detailed numbers